Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,
RNAi therapeutics company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) said Olivier Brandicourt will join its board. Brandicourt, who retired as CEO of Sanofi (Euronext:SAN; NASDAQ:SNY) last year, also plans to join Blackstone Group as a senior adviser.
Bayer AG (Xetra:BAYN) said Norbert Winkeljohann will succeed Werner Wenning as chairman, effective April 28. Along with being on the pharma's board, Winkeljohann is chairman of PricewaterhouseCoopers Europe SE.